Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Airlift Bioreactors Market Growth Analysis: How Will Revenue Trend Over The Forecast Period?
The airlift bioreactors market has shown strong expansion in recent years. This market is expected to increase from $4.32 billion in 2025 to $4.75 billion in 2026, registering a compound annual growth rate (CAGR) of 10.0%. The growth observed in the historic period is attributable to the expansion of biopharmaceutical manufacturing capacity, increased use of microbial fermentation processes, growth in enzyme and biofuel production, rising adoption of disposable bioprocessing systems, and advancements in large-scale cell culture techniques.
The market for airlift bioreactors is anticipated to experience robust expansion over the upcoming years. This market is projected to reach a valuation of $6.71 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.0%. Several factors are expected to drive this growth during the forecast period, including the surging demand for biologics and vaccines, heightened investments in sustainable bio-manufacturing practices, the broadening of contract manufacturing services, an increased emphasis on process intensification, and the rising uptake of intelligent bioreactor control systems. Key trends characterizing the forecast period encompass the increasing integration of single-use airlift bioreactor systems, the escalating need for extensive aerobic fermentation solutions, the wider implementation of advanced process monitoring sensors, the development of more modular and scalable bioreactor designs, and a heightened emphasis on energy-efficient mixing methods.
Get A Free Sample Report With In-Depth Market Insights:
Airlift Bioreactors Market Growth Factors Behind Sustained Expansion
Increased demand for biopharmaceutical products is anticipated to drive the expansion of the airlift bioreactors market in the future. Biopharmaceutical products are pharmaceuticals originating from living organisms or created through biotechnological methods, such as recombinant DNA technology, cell cultures, and monoclonal antibodies. The escalating need for biopharmaceutical products stems from factors like advancements in cell culture technologies, a rise in chronic illnesses, the prevalence of age-related conditions, novelties in bioprocessing, and progress in genomics. Airlift bioreactors offer significant advantages in the creation of biopharmaceutical products, owing to their distinct design and operational benefits, finding application in the manufacturing of therapeutic proteins, monoclonal antibodies, and vaccines. To illustrate, a report from August 2023 by the US-based non-profit organization, Alliance for Regenerative Medicine, indicated that global cell, gene, and tissue-engineering therapeutic developers reached 2,760 in the first quarter of 2023, marking a 101% increase from 1,369 in the first quarter 2022. Consequently, the growing demand for biopharmaceutical products is propelling the expansion of the airlift bioreactors market.
Airlift Bioreactors Market Segmentation: How Does The Market Break Down By Category?
The airlift bioreactors market covered in this report is segmented –
1) By Product: Internal Airlift Loop Bioreactor, External Airlift Loop Bioreactor
2) By Capacity: 5 Liters, 7 Liters, 10 Liters, 30 Liters
3) By Usage: Single-Use Or Disposal, Reusable
4) By Production Scale: Laboratory Scale, Pilot-Scale, Large Scale
5) By End-User: Biopharmaceutical Companies, Contract Research Organizations (CROs) Or Contract Development And Manufacturing Organizations (CDMOs), Research And Development Companies
Subsegments:
1) By Internal Airlift Loop Bioreactor: Circulating Bioreactor, Non-Circulating Bioreactor
2) By External Airlift Loop Bioreactor: Single-Stage External Airlift Bioreactor, Multi-Stage External Airlift Bioreactor
Airlift Bioreactors Market Industry Trends Fueling Future Revenue Growth
Leading companies within the airlift bioreactor market are concentrating on developing sophisticated cloud-integrated systems to boost process efficiency, enhance automation, and enable remote oversight. These cloud-integrated solutions merge physical bioreactors with live remote monitoring, automated controls, and AI-powered optimization, empowering bioprocess teams to manage experiments with increased precision and speed. For example, in April 2025, Culture Biosciences, a US-based firm that assists biotech companies in developing and scaling manufacturing processes in the cloud, unveiled Stratyx 250, featuring a mobile, cloud-integrated bioreactor design. This system offers cart-based mobility for easy relocation within laboratories, integrates Culture Console software for real-time remote observation and automation, and utilizes single-use bioreactor technology to reduce cleaning needs and downtime. Stratyx 250 also leverages artificial intelligence and machine learning to refine bioprocesses, resulting in 25% faster development timelines, a 30% improvement in scale-up success, and a 16% lower total cost per run. Furthermore, it is compatible with a Cytiva 250 mL consumable, which replicates large-scale reactor conditions within a smaller platform, supporting efficient process development and a more rapid optimization workflow.
Airlift Bioreactors Market Competitive Overview And Top Companies
Major companies operating in the airlift bioreactors market are Sartorius AG, Cytiva, Applikon Biotechnology B.V., Cellexus International Ltd, Bionet Innovación S.L., Solida Biotech GmbH, Belach Bioteknik AB, OmniBRx Biotechnologies Pvt. Ltd., Electrolab Biotech Ltd., LABOAO Instrument Equipment Co. Ltd., Bailun Biotechnology Co. Ltd., BioReactor Sciences Inc., Shree Biocare Solutions Pvt. Ltd., Lab1st Scientific Co. Ltd., Cedarstone Industry LLC, New Brunswick Scientific Co. Inc., Eppendorf AG, Kuhner AG, Thermo Fisher Scientific Inc., Lonza Group AG, ABEC Inc., Pierre Guérin SAS, Bioengineering AG
View The Full Airlift Bioreactors Market Report:
Airlift Bioreactors Market Regional Analysis And Top Geography
North America was the largest region in the airlift bioreactor market in 2025. The regions covered in the airlift bioreactors market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.
